Key result
The EuroScore II predicted 30-day mortality with an area under the curve of 0.70, outperforming the logistic EuroScore (AUC 0.61) and STS-PROM score (AUC 0.59).
Why the study?
Does the EuroScore II better predict mortality compared to logistic EuroScore and STS-PROM in patients undergoing TAVI?
Cohort (n=350)
Does the EuroScore II better predict mortality compared to logistic EuroScore and STS-PROM in patients undergoing TAVI?
Effect estimate: AUC 0.70
p-value: p=<0.001
The EuroScore II outperforms the logistic EuroScore and STS-PROM score in predicting short- and long-term mortality in patients undergoing TAVI.
No takes yet. Share an insight, caveat, or question.
May improve TAVI risk stratification; extends validation data but leaves open prospective outcome impact.
Stähli et al. (2013) conducted a cohort in Transcatheter aortic valve implantation (TAVI) (n=350). EuroScore II vs. Logistic EuroScore and STS-PROM score was evaluated on 30-day mortality (AUC 0.70, p=<0.001). The EuroScore II predicted 30-day mortality with an area under the curve of 0.70, outperforming the logistic EuroScore (AUC 0.61) and STS-PROM score (AUC 0.59).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: